Switch from Intravenous to Subcutaneous Immunoglobulin in CIDP and MMN: 12 Months Results from an Observational Study.
- DOI
- 10.1007/s40120-025-00848-1
- Published
- 2026 Feb
- Container
- Neurology and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40120-025-00848-1,
title = {Switch from Intravenous to Subcutaneous Immunoglobulin in CIDP and MMN: 12 Months Results from an Observational Study.},
author = {Gingele S and Saparilla Pietschmann AC and Jendretzky KF and Koch M and Körner GM and Siemer JM and Konen FF and Hümmert MW and Salge F and von Hörsten J and Seeliger T and Körner S and Skripuletz T},
year = {2026},
journal = {Neurology and therapy},
doi = {10.1007/s40120-025-00848-1},
url = {https://doi.org/10.1007/s40120-025-00848-1}
}RIS
TY - JOUR TI - Switch from Intravenous to Subcutaneous Immunoglobulin in CIDP and MMN: 12 Months Results from an Observational Study. AU - Gingele S AU - Saparilla Pietschmann AC AU - Jendretzky KF AU - Koch M AU - Körner GM AU - Siemer JM AU - Konen FF AU - Hümmert MW AU - Salge F AU - von Hörsten J AU - Seeliger T AU - Körner S AU - Skripuletz T PY - 2026 JO - Neurology and therapy DO - 10.1007/s40120-025-00848-1 UR - https://doi.org/10.1007/s40120-025-00848-1 ER -
APA
S, G., AC, S. P., KF, J., M, K., GM, K., JM, S., FF, K., MW, H., F, S., J, V. H., T, S., S, K., & T, S. (2026). Switch from Intravenous to Subcutaneous Immunoglobulin in CIDP and MMN: 12 Months Results from an Observational Study.. Neurology and therapy. https://doi.org/10.1007/s40120-025-00848-1
Source records
- pubmed · retrieved 2026-09-26T20:07:25.325Z